Unsupported browser detected
Your browser appears to be unsupported. Because of this, portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to stabilize the supply and to decrease the cost of artemisinin, an essential precursor for ACTs for malaria treatment, through the development of scalable cost competitive semisynthetic manufacturing approaches to artemisinin
Grantee
Division
Global Health
Date
MARCH 2018
Region Served
GLOBAL
Committed Amount
$364,780
Grant Topic
Research and Learning Opportunities
Duration (Months)
27
Grantee Location
Paris, France
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.